Claoué Charles
Hartswood Hospital, Brentwood, United Kingdom.
J Cataract Refract Surg. 2004 Oct;30(10):2088-91. doi: 10.1016/j.jcrs.2004.05.007.
To compare the efficacy (functional vision, spectacle dependence) of the Array multifocal intraocular lens (IOL) (Advanced Medical Optics) and the 1CU accommodating IOL (HumanOptics AG).
Hartswood Hospital, Brentwood, United Kingdom.
This prospective study comprised patients scheduled to have standard phacoemulsification surgery with IOL implantation. Patients expressing a preference for spectacle independence were allocated to the Array multifocal IOL group. Those expressing no preference received the 1CU accommodating IOL. Efficacy measures included distance and near uncorrected visual acuity (UCVA), dynamic retinoscopy, and patient-reported spectacle independence.
Seventeen patients (34 eyes) had bilateral implantation of the Array multifocal IOL, and 5 patients (9 eyes) had implantation of the 1CU accommodating IOL. Six to 18 months after surgery, 82.4% of eyes in the multifocal IOL group and 77.8% in the accommodating IOL group achieved a distance UCVA of 20/20 (Snellen) or better; the difference between groups was not significant. However, a significantly greater proportion in the multifocal IOL group than in the accommodating IOL group (76.5% versus 44.4%) achieved a near UCVA of N5 (Snellen 20/40) or better (P=.0068). Sixteen patients (94.1%) with Array IOLs and 2 patients (50.0%) with 1CU IOLs reported spectacle independence. Dynamic retinoscopy showed that the mean accommodative effect in the 1CU group was 0.44 diopter.
In this single-surgeon single-site study, a greater proportion of Array multifocal IOL recipients than 1CU IOL recipients achieved functional near visual acuity. Only 1 patient with an Array IOL required corrective spectacles at the last visit.
比较Array多焦点人工晶状体(IOL)(Advanced Medical Optics公司)与1CU可调节人工晶状体(HumanOptics AG公司)的疗效(功能性视力、对眼镜的依赖程度)。
英国布伦特伍德的哈茨伍德医院。
这项前瞻性研究纳入了计划接受标准白内障超声乳化吸除联合人工晶状体植入手术的患者。表示希望不依赖眼镜的患者被分配到Array多焦点人工晶状体组。那些没有偏好的患者接受1CU可调节人工晶状体。疗效指标包括远、近未矫正视力(UCVA)、动态视网膜检影法以及患者报告的不依赖眼镜情况。
17例患者(34只眼)双侧植入Array多焦点人工晶状体,5例患者(9只眼)植入1CU可调节人工晶状体。术后6至18个月,多焦点人工晶状体组82.4%的眼和可调节人工晶状体组77.8%的眼远UCVA达到20/20(Snellen)或更好;两组之间差异无统计学意义。然而,多焦点人工晶状体组达到近UCVA为N5(Snellen 20/40)或更好的比例显著高于可调节人工晶状体组(76.5%对44.4%)(P = 0.0068)。16例(94.1%)植入Array人工晶状体的患者和2例(50.0%)植入1CU人工晶状体的患者报告不依赖眼镜。动态视网膜检影显示1CU组的平均调节效果为0.44屈光度。
在这项单医生单中心研究中,接受Array多焦点人工晶状体的患者比接受1CU人工晶状体的患者获得功能性近视力的比例更高。最后一次随访时,只有1例植入Array人工晶状体的患者需要矫正眼镜。